Elsevier

Life Sciences

Volume 52, Issue 16, 1993, Pages 1329-1342
Life Sciences

Minireview
Peripheral-type benzodiazepine receptors

https://doi.org/10.1016/0024-3205(93)90168-3Get rights and content

Abstract

Since their first description as anomalous high affinity diazepam binding sites in rat peripheral tissues, the peripheral-type benzodiazepine receptor (PBR) has been increasingly studied to better understand nonneural effects of the benzodiazepines. The mammalian PBR is ubiquitously distributed with high concentrations in the outer mitochondrial membrane of secretory tissues. In regions of the brain, the density of PBR can equal or exceed the density of central-type benzodiazepine receptors. High affinity PK 11195 binding is diagnostic for the receptor while the affinity for benzodiazepines is species dependent. Recent cDNA cloning of a PBR component, the isoquinoline binding protein (IBP), shows no apparent sequence homology with any GABAA receptor subunits known to comprise central benzodiazepine receptor subtypes. The PBR seems at best only distantly related to CBRs. Recent advances in the pharmacology, biochemistry and molecular biology of the PBR are reviewed.

References (119)

  • R.C. Speth et al.

    Life Sci.

    (1978)
  • C. Braestrup et al.

    Eur. J. Pharmacol.

    (1978)
  • C.A. Klepner et al.

    Pharmacol. Biochem. Behav.

    (1979)
  • R.F. Squires et al.

    Pharmacol. Biochem. Behav.

    (1979)
  • J.W. Regan et al.

    Eur. J. Pharmacol.

    (1980)
  • S.Z. Langer et al.

    Pharmacol. Biochem. Behav.

    (1988)
  • R.R.H. Anholt

    Trends Pharmacol. Sci.

    (1986)
  • A.S. Basile et al.

    Brain Res.

    (1986)
  • A.L. Parola et al.

    Life Sci.

    (1991)
  • P. Moingeon et al.

    Life Sci.

    (1984)
  • G.B. O'Beirne et al.

    Biochem. Pharmacol.

    (1984)
  • D. Valtier et al.

    Neuropharmacol.

    (1987)
  • J.M. Olson et al.

    Eur. J. Pharmacol.

    (1988)
  • S. Mihara et al.

    Life Sci.

    (1989)
  • W.C. Broaddus et al.

    Brain Res.

    (1990)
  • R.T. McCabe et al.

    FEBS Let.

    (1989)
  • G. LeFur et al.

    Life Sci.

    (1983)
  • M. Awad et al.

    Biochem. Pharmacol.

    (1989)
  • M.C. Dubroeucq et al.

    Eur. J. Pharmacol.

    (1986)
  • R. Skowronski et al.

    Eur. J. Pharmacol.

    (1988)
  • A.L. Parola et al.

    J. Biol. Chem.

    (1991)
  • G. LeFur et al.

    Life Sci.

    (1983)
  • H.E. Laird et al.

    Eur. J. Pharmacol.

    (1989)
  • V. Papadopoulos et al.

    J. Biol. Chem.

    (1990)
  • R. Skowronski et al.

    Eur. J. Pharmacol.

    (1987)
  • J. Benavides et al.

    Life Sci.

    (1984)
  • M. Awad et al.

    Life Sci.

    (1988)
  • K. Beaumont et al.

    Biochem. Pharmacol.

    (1988)
  • H.W. Lueddens et al.

    Eur. J. Pharmacol.

    (1987)
  • E. Costa et al.

    Life Sci.

    (1991)
  • C.R. Mantione et al.

    Biochem. Pharmacol.

    (1988)
  • D.R. Gehlert et al.

    Eur. J. Pharmacol.

    (1983)
  • R.R. Anholt et al.

    J. Biol. Chem.

    (1986)
  • K. Ikezaki et al.

    Cancer Let.

    (1990)
  • A.D. Beavis

    J. Biol. Chem.

    (1989)
  • J.C. Larcher et al.

    Eur. J. Pharmacol.

    (1989)
  • K.E. Krueger et al.

    J. Biol. Chem.

    (1990)
  • M. Mestre et al.

    Life Sci.

    (1984)
  • M. Mestre et al.

    Life Sci.

    (1985)
  • M. Mestre et al.

    Life Sci.

    (1986)
  • W.B. Mendelson et al.

    Eur. J. Pharmacol.

    (1984)
  • J.J. Descombes et al.

    Eur. J. Pharmacol.

    (1985)
  • A.J. Doble et al.

    Eur. J. Pharmacol.

    (1985)
  • H. Shibata et al.

    Biochem. Biophys. Res. Comm.

    (1986)
  • C. Braestrup et al.
  • H. Mohler et al.

    Science

    (1977)
  • R.C. Speth et al.
  • J.F. Tallman et al.

    Science

    (1980)
  • E. Costa et al.

    Ann. Rev. Pharmacol. Toxicol.

    (1979)
  • E. Costa et al.

    Life Sci.

    (1975)
  • Cited by (0)

    3

    Upjohn Pharmacology and Toxicology Fellow awarded by the American Foundation for Pharmaceutical Education.

    View full text